These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12746120)

  • 1. Hylan G-F 20 induces delayed foreign body inflammation in Guinea pigs and rabbits.
    Sasaki M; Miyazaki Y; Takahashi T
    Toxicol Pathol; 2003; 31(3):321-5. PubMed ID: 12746120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of hylan g-f 20 in Guinea pigs and mice.
    Sasaki M; Miyazaki T; Nakamura T; Takahashi T; Miyauchi S; Iwata H
    J Rheumatol; 2004 May; 31(5):943-50. PubMed ID: 15124255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of cross-linked hyaluronate (Gel-200) for the treatment of knee osteoarthritis.
    Ishikawa M; Yoshioka K; Urano K; Tanaka Y; Hatanaka T; Nii A
    Osteoarthritis Cartilage; 2014 Nov; 22(11):1902-9. PubMed ID: 25153804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hylan gel biomaterial: dermal and immunologic compatibility.
    Larsen NE; Pollak CT; Reiner K; Leshchiner E; Balazs EA
    J Biomed Mater Res; 1993 Sep; 27(9):1129-34. PubMed ID: 8126011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native hyaluronan produces less hypersensitivity than cross-linked hyaluronan.
    Goomer RS; Leslie K; Maris T; Amiel D
    Clin Orthop Relat Res; 2005 May; (434):239-45. PubMed ID: 15864059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly injections of Hylan G-F 20 delay cartilage degeneration in partial meniscectomized rat knees.
    Yanagisawa K; Muneta T; Ozeki N; Nakagawa Y; Udo M; Saito R; Koga H; Tsuji K; Sekiya I
    BMC Musculoskelet Disord; 2016 Apr; 17():188. PubMed ID: 27118194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No conclusive evidence that histologically found granulomas and acute local reactions following hylan G-F 20 injections are related or have clinical significance.
    Waddell DD; Beyer A; Thompson TL; Morawiak J; Elkins C; Rosenberg A; Spitzer A
    J Knee Surg; 2014 Apr; 27(2):99-104. PubMed ID: 23873318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and immunological responses to hyaluronan preparations. Study of a murine biocompatibility model.
    Ottaviani RA; Wooley P; Song Z; Markel DC
    J Bone Joint Surg Am; 2007 Jan; 89(1):148-57. PubMed ID: 17200322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis.
    Zhao H; Liu H; Liang X; Li Y; Wang J; Liu C
    BioDrugs; 2016 Oct; 30(5):387-396. PubMed ID: 27435213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hylan G-F 20 maintains cartilage integrity and decreases osteophyte formation in osteoarthritis through both anabolic and anti-catabolic mechanisms.
    Li P; Raitcheva D; Hawes M; Moran N; Yu X; Wang F; Matthews GL
    Osteoarthritis Cartilage; 2012 Nov; 20(11):1336-46. PubMed ID: 22809835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized trial comparing the efficacy of single 6-ml injection of hylan G-F 20 and hyaluronic acid for primary knee arthritis: a preliminary study.
    Khanasuk Y; Dechmaneenin T; Tanavalee A
    J Med Assoc Thai; 2012 Oct; 95 Suppl 10():S92-7. PubMed ID: 23451445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an immunogenic candidate for the elicitation of severe acute inflammatory reactions (SAIRs) to hylan G-F 20.
    Hamburger M; Settles M; Teutsch J
    Osteoarthritis Cartilage; 2005 Mar; 13(3):266-8. PubMed ID: 15727894
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological response to bolus versus multiple injections of hylan G-F 20 (Synvisc) in a murine biocompatibility model.
    Markel DC; Jackson NM; Esquivel AO; Ren W; Flynn JC
    J Biomed Mater Res B Appl Biomater; 2014 Oct; 102(7):1375-80. PubMed ID: 24500880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linked hyaluronan (Hylan B gel): a new injectable remedy for treatment of vocal fold insufficiency--an animal study.
    Hallén L; Johansson C; Laurent C
    Acta Otolaryngol; 1999 Jan; 119(1):107-11. PubMed ID: 10219396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hylan b gel as a soft-tissue augmentation implant material.
    Piacquadio D; Jarcho M; Goltz R
    J Am Acad Dermatol; 1997 Apr; 36(4):544-9. PubMed ID: 9092739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synvisc perisynovitis.
    Zardawi IM; Chan I
    Pathology; 2001 Nov; 33(4):519-20. PubMed ID: 11827424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections?
    Pullman-Mooar S; Mooar P; Sieck M; Clayburne G; Schumacher HR
    J Rheumatol; 2002 Dec; 29(12):2611-4. PubMed ID: 12465161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc].
    Shibata K; Matsuda K; Wada H; Aruga F; Yamada Y
    Arzneimittelforschung; 1991 Oct; 41(10):1048-52. PubMed ID: 1799382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis.
    Marshall KW; Manolopoulos V; Mancer K; Staples J; Damyanovich A
    J Orthop Res; 2000 May; 18(3):416-25. PubMed ID: 10937628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of oxyphenbutazone on immunologic reactions. 2. Passive cutaneous anaphylaxis (PCA) treated with oxyphenbutazone, cortisone and cyclophosphamide].
    Horsch A; Rapp W
    Arzneimittelforschung; 1971 Jun; 21(6):769-72. PubMed ID: 5109255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.